These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27841142)

  • 41. Current status and future directions in induction chemotherapy for head and neck cancer.
    Argiris A
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):57-74. PubMed ID: 23541071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems.
    Ervin TJ; Karp DD; Weichselbaum RR; Posner MR; Fabian RL; Miller D
    Ann Otol Rhinol Laryngol; 1981; 90(5 Pt 1):506-11. PubMed ID: 7030176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer.
    Guntinas-Lichius O; Appenrodt S; Veelken F; Krug B
    Laryngoscope; 2006 Apr; 116(4):613-8. PubMed ID: 16585868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
    Haddad RI; Wirth L; Posner MR
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in the treatment of head and neck tumors. I. Chemotherapy].
    Stupp R; Vokes EE
    Strahlenther Onkol; 1995 Jan; 171(1):12-7. PubMed ID: 7839300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
    Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
    Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cancer chemotherapy of the upper aerodigestive tract].
    Védrine L; Chargari C; Le Moulec S; Fayolle M; Ceccaldi B; Bauduceau O
    Cancer Radiother; 2008 Mar; 12(2):110-9. PubMed ID: 18187355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The expanding role of systemic therapy in head and neck cancer.
    Cohen EE; Lingen MW; Vokes EE
    J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current status and importance of antineoplastic chemotherapy of head and neck neoplasms].
    Weidauer H
    Arch Otorhinolaryngol Suppl; 1983; 2():118-45. PubMed ID: 6586133
    [No Abstract]   [Full Text] [Related]  

  • 51. Intra-arterial infusion for head and neck cancers.
    Geriatrics; 1973 Jul; 28(7):118-9. PubMed ID: 4575888
    [No Abstract]   [Full Text] [Related]  

  • 52. Induction chemotherapy in head and neck cancer: are we too ambitious?
    Specenier P
    Future Oncol; 2014 Feb; 10(3):337-40. PubMed ID: 24559441
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical research, national studies and grant applications: United Kingdom National Multidisciplinary Guidelines.
    Stafford N
    J Laryngol Otol; 2016 May; 130(S2):S216-S217. PubMed ID: 27841137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experiences with chemotherapy for progressive cancer of the head and neck metastasizing to the remote parts].
    Kawabe Y; Yokoi H; Kondo T
    Jibiinkoka; 1966 Nov; 38(11):1199-203. PubMed ID: 6009820
    [No Abstract]   [Full Text] [Related]  

  • 55. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
    Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
    Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Head and neck cancer.
    Taylor SG
    Cancer Chemother Biol Response Modif; 1990; 11():416-31. PubMed ID: 2223401
    [No Abstract]   [Full Text] [Related]  

  • 58. Reduction of distant metastases in head and neck cancer with concomitant chemotherapy.
    Brockstein BE
    J Clin Oncol; 2000 Sep; 18(18):3320-1. PubMed ID: 10986067
    [No Abstract]   [Full Text] [Related]  

  • 59. Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study.
    Noronha V; Goswami C; Patil S; Joshi A; Patil VM; Murthy V; Arya S; Juvekar S; Goud S; Prabhash K
    J Laryngol Otol; 2016 Sep; 130(9):833-42. PubMed ID: 27456399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
    Cocks H; Ah-See K; Capel M; Taylor P
    J Laryngol Otol; 2016 May; 130(S2):S198-S207. PubMed ID: 27841131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.